Clearmind Medicine Inc
CNSX:CMND
Clearmind Medicine Inc
Research & Development
Clearmind Medicine Inc
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
C
|
Clearmind Medicine Inc
CNSX:CMND
|
Research & Development
-$1.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Abcellera Biologics Inc
NASDAQ:ABCL
|
Research & Development
-$167.3m
|
CAGR 3-Years
-39%
|
CAGR 5-Years
-75%
|
CAGR 10-Years
N/A
|
|
|
B
|
Bright Minds Biosciences Inc
CNSX:DRUG
|
Research & Development
-CA$11.1m
|
CAGR 3-Years
3%
|
CAGR 5-Years
-125%
|
CAGR 10-Years
N/A
|
|
|
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
|
Research & Development
-$29.7m
|
CAGR 3-Years
14%
|
CAGR 5-Years
10%
|
CAGR 10-Years
-7%
|
|
|
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
|
Research & Development
-$105.2m
|
CAGR 3-Years
-41%
|
CAGR 5-Years
-61%
|
CAGR 10-Years
-152%
|
|
|
Eupraxia Pharmaceuticals Inc
TSX:EPRX
|
Research & Development
-CA$14.9m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-38%
|
CAGR 10-Years
N/A
|
|
Clearmind Medicine Inc
Glance View
Clearmind Medicine, Inc. operates as a mineral resource company, which acquires, explores, develops, and operates mineral resource assets in Canada. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2018-05-15. The firm is focused on the discovery and development of novel psychedelic derived therapeutics to solve health problems including alcohol use disorder. The firm is engaged in the research and development of compounds derived from psychedelics and commercializes them as regulated medicines, foods, or supplements. The firm's portfolio consists of patent families such as binge behavior regulators and alcoholic beverage substitutes.
See Also
What is Clearmind Medicine Inc's Research & Development?
Research & Development
-1.5m
USD
Based on the financial report for Oct 31, 2023, Clearmind Medicine Inc's Research & Development amounts to -1.5m USD.
What is Clearmind Medicine Inc's Research & Development growth rate?
Research & Development CAGR 1Y
50%
Over the last year, the Research & Development growth was 50%.
